Status:
UNKNOWN
A Double-Blind Study of Buprenorphine Treatment of Acute Suicidality
Lead Sponsor:
Abarbanel Mental Health Center
Collaborating Sponsors:
Ministry of Health, Israel
Conditions:
Depression
Suicidal Ideation
Eligibility:
All Genders
18-60 years
Phase:
PHASE3
Brief Summary
The acutely suicidal patient presents a complex and dangerous clinical dilemma. Many suicidal patients receive antidepressant medications, but the onset of action of these medications is at least thre...
Eligibility Criteria
Inclusion
- depression
Exclusion
- substance or alcohol abuse
- psychosis
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2008
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00863291
Start Date
November 1 2007
End Date
November 1 2008
Last Update
March 17 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Abarbanel MHC
Bat Yam, Israel, 59100